[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630094":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":57,"collaborators":10,"id":60,"slug":10,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":10,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":10,"enrollmentInfo":68,"targetDuration":10,"studyType":71,"phases":10,"briefSummary":72,"conditions":73,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8,13,16],{"label":9,"type":10,"description":10,"interventionNames":11},"Aortic Intervention",null,[12],"Diagnostic Test: Echocardiogram",{"label":14,"type":10,"description":10,"interventionNames":15},"Mitral Intervention",[12],{"label":17,"type":10,"description":10,"interventionNames":18},"Tricuspid intervention",[12],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DIAGNOSTIC_TEST","Echocardiogram","An echocardiogram will be performed during the patient's routinely scheduled right heart catheterization.",[9,14,17],[26],{"name":27,"affiliation":5,"role":28},"Barry Borlaug, MD","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Annabelle Fuenffinger","CONTACT","507-422-3801","fuenffinger.annabelle@mayo.edu",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Mayo Clinic in Rochester","RECRUITING","Rochester","Minnesota","55905","United States",{"type":44,"coordinates":45},"Point",[46,47],-92.4699,44.02163,{"lat":47,"lon":46},[50,53,56],{"name":51,"role":32,"phone":52,"phoneExt":10,"email":10},"Dr. Borlaug's Research Team","(507) 255-2200",{"name":27,"role":32,"phone":54,"phoneExt":10,"email":55},"(507) 255-1051","Borlaug.Barry@mayo.edu",{"name":27,"role":28,"phone":10,"phoneExt":10,"email":10},{"type":28,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Barry Borlaug","Principal Investigator","100630094",false,"NCT07483203","A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease","Clinical Implications of Pulmonary Vascular Disease in Valvular Heart Disease","Inclusion Criteria:\n\n* ≥18 years old; AND\n* Scheduled for valve procedures\n\nExclusion Criteria:\n\n* Congenital heart disease (except for bicuspid aortic valve), OR\n* Carcinoid heart disease, OR\n* Valvular mass, OR\n* Endocarditis, OR\n* Any other condition that, in the opinion of the investigator, would impair their ability to complete the study","ALL","18 Years",{"count":69,"type":70},600,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.",[74,75],"Pulmonary Vascular Disease","Valvular Heart Disease","2026-06-16",{"date":78,"type":79},"2026-06-18","ACTUAL",{"date":81,"type":79},"2026-04-28",{"date":83,"type":70},"2028-05",{"name":5,"class":6},1]